3-Year Clinical Outcome of the DUTCH PEERS (TWENTE II) Randomized Trial: Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Versus Platinum-Chromium Everolimus-Eluting Promus Element Stents in All-Comer Patients

被引:0
|
作者
von Birgelen, Clemens [1 ,2 ]
van der Heijden, Liefke C. [1 ]
Kok, Marlies M. [1 ]
Danse, Peter W. [3 ]
Jessurun, Gillian A. [4 ]
Hautvast, Raymond [5 ]
Hartmann, Marc [1 ]
Gin, Melvyn Tjon Joe [3 ]
Schramm, Alexander [4 ]
Louwerenburg, Hans W. [1 ]
Lowik, Marije M. [1 ]
Linssen, Gerard C. [6 ]
Doggen, Carine J. [7 ]
Stoel, Martin G. [1 ]
机构
[1] Thoraxctr Twente, Enschede, Netherlands
[2] Univ Twente, NL-7500 AE Enschede, Netherlands
[3] Rijnstate Hosp, Arnhem, Netherlands
[4] Scheper Hosp, Emmen, Netherlands
[5] Med Ctr Alkmaar, Alkmaar, Netherlands
[6] Ziekenhuisgrp Twente, Almelo, Netherlands
[7] MIRA Inst Biomed Technol & Tech Med, Enschede, Netherlands
关键词
Everolimus-eluting stents; Randomized clinical trial; Zotarolimus-eluting stent;
D O I
10.1016/j.jacc.2015.08.1040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TCT-570
引用
收藏
页码:B231 / B231
页数:1
相关论文
共 41 条
  • [31] Clinical Outcome of Complex Patients Treated With Second-Generation Zotarolimus-Eluting Resolute vs. Everolimus-Eluting Xience V Stents: Insight From 2-Year Follow-up of TWENTE
    Sen, Hanim
    Tandjung, Kenneth
    Lam, Ming Kai
    Basalus, Mounir W.
    Stoel, Martin G.
    de Man, F.
    Louwerenburg, Hans W.
    van Houwelingen, Gert
    Linssen, Gerard C.
    Nienhuis, Mark B.
    van der Palen, Job
    von Birgelen, Clemens
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B55 - B55
  • [32] Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial
    Song, Lei
    Guan, Changdong
    Yu, Mengyue
    Sun, Zhongwei
    Fu, Guosheng
    He, Yong
    Jia, Shaobin
    Chen, Jiyan
    Qi, Feng
    Bai, Jie
    Li, Wei
    Ge, Junbo
    Han, Yaling
    Gao, Runlin
    AMERICAN HEART JOURNAL, 2024, 275 : 53 - 61
  • [33] EVEROLIMUS-ELUTING XIENCE PRIME/X PEDITION VERSUS ZOTAROLIMUS-ELUTING RESOLUTE INTEGRITY STENTS IN PATIENTS WITH DIABETES MELLITUS AND SMALL VESSEL DISEASE: AN ANALYSIS FROM THE 2-YEAR PROSPECTIVE RANDOMIZED COPERES STUDY
    Yun, Wonsik
    Kim, Yisik
    Lee, Sang-Rok
    Chae, Jei-Keon
    Lee, Ja-Yeon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1501 - 1501
  • [34] A RANDOMIZED COMPARISON OF SECOND-GENERATION ZOTAROLIMUS-ELUTING RESOLUTE STENTS VERSUS EVEROLIMUS-ELUTING XIENCE V STENTS IN REAL-WORLD PATIENTS: 4-YEAR LONG-TERM CLINICAL OUTCOMES OF LISA-ERX TRIAL
    Kim, Yisik
    Chae, Jei Keon
    Yoon, Ji Young
    Song, Soo Kyeong
    Jung, Lae Young
    Lee, Sun Hwa
    Lee, Sang Rok
    Lee, Kyoung Seok
    Ko, Jae Ki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A51 - A51
  • [35] Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomized Trial (TWENTE II)
    Sen, Hanim
    Lam, Ming Kai
    Loewik, Marije M.
    Danse, Peter W.
    Jessurun, Gillian A. J.
    van Houwelingen, K. Gert
    Anthonio, Rutger L.
    Gin, R. Melvyn Tjon Joe
    Hautvast, Raymond W. M.
    Louwerenburg, J. W.
    de Man, Frits H. A. F.
    Stoel, Martin G.
    van der Heijden, Liefke C.
    Linssen, Gerard C. M.
    IJzerman, Maarten J.
    Tandjung, Kenneth
    Doggen, Carine J. M.
    von Birgelen, Clemens
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (07) : 889 - 899
  • [36] LONG TERM COMPARISON OF PLATINUM CHROMIUM-BASED EVEROLIMUSE-LUTING STENT VERSUS COBALT CHROMIUM-BASED ZOTAROLIMUS-ELUTING STENT: 3-YEAR OUTCOMES FROM THE HOST-ASSURE RANDOMIZED CLINICAL TRIAL
    Park, K.
    Kim, C.
    Kang, J.
    Kim, H. -S.
    CARDIOLOGY, 2018, 140 : 330 - 330
  • [37] Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents 2-Year Follow-Up of the Randomized TWENTE Trial
    Tandjung, Kenneth
    Sen, Hanim
    Lam, Ming Kai
    Basalus, Mounir W. Z.
    Louwerenburg, J. W.
    Stoel, Martin G.
    van Houwelingen, K. Gert
    de Man, Frits H. A. F.
    Linssen, Gerard C. M.
    Said, Salah A. M.
    Nienhuis, Mark B.
    Lowik, Marije M.
    Verhorst, Patrick M. J.
    van der Palen, Job
    von Birgelen, Clemens
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (24) : 2406 - 2416
  • [38] Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial
    Natsuaki, Masahiro
    Kozuma, Ken
    Morimoto, Takeshi
    Kadota, Kazushige
    Muramatsu, Toshiya
    Nakagawa, Yoshihisa
    Akasaka, Takashi
    Igarashi, Keiichi
    Tanabe, Kengo
    Morino, Yoshihiro
    Ishikawa, Tetsuya
    Nishikawa, Hideo
    Awata, Masaki
    Abe, Mitsuru
    Okada, Hisayuki
    Takatsu, Yoshiki
    Ogata, Nobuhiko
    Kimura, Kazuo
    Urasawa, Kazushi
    Tarutani, Yasuhiro
    Shiode, Nobuo
    Kimura, Takeshi
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (10)
  • [39] 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
    Alfonso, Fernando
    Jose Perez-Vizcayno, Maria
    Cuesta, Javier
    Garcia del Blanco, Bruno
    Garcia-Touchard, Arturo
    Ramon Lopez-Minguez, Jose
    Masotti, Monica
    Zueco, Javier
    Cequier, Angel
    Velazquez, Maite
    Moreno, Raul
    Mainar, Vicente
    Dominguez, Antonio
    Moris, Cesar
    Molina, Eduardo
    Rivero, Fernando
    Jimenez-Quevedo, Pilar
    Gonzalo, Nieves
    Fernandez-Perez, Cristina
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (10) : 981 - 991
  • [40] Four-Year Clinical Outcomes in 'Real-World' Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent: Results from the PROMUS Element Plus US Post-Approval Study (PE-Plus PAS)
    Kandzari, David
    Lee, Peter Ver
    Chhabra, Anil
    Grodin, Jerrold
    Bartlett, Maria
    Zelman, Richard
    Marquardt, Walt
    Christen, Thomas
    Meredith, Ian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B309 - B310